CDC Amends Public Comments Policy Amid Censorship Lawsuit
By Samantha Flom A webpage detailing the Centers for Disease Control and Prevention’s policy for moderating public comments has been revised amid litigation accusing the agency of censorship. The webpage outlines the CDC’s “Guidelines for Public Comments” on its websites, social media profiles, blogs, and applications. It also states that comments found to violate agency policy may be…
More Stories
Evercore ISI Issues Positive Forecast for American Airlines Group (NASDAQ:AAL) Stock Price
American Airlines Group (NASDAQ:AAL – Get Free Report) had its target price upped by equities research analysts at Evercore ISI...
AerSale Corporation Evaluates Progress on Insurance Claim Following Fire Incident
AerSale Corporation, a leader in the aviation aftermarket solutions sector, recently provided an update on the aftermath of a fire...
Collegium Pharmaceutical Announces 2025 Financial Guidance and Corporate Presentation – What Investors Need to Know
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) recently disclosed its full-year revenue, adjusted operating expense, and adjusted EBITDA guidance for 2025 in...
Greenwave Technology Solutions, Inc. Cancels Special Meeting of Stockholders
Greenwave Technology Solutions, Inc. filed a Form 8-K with the Securities and Exchange Commission on January 8, 2025, announcing the...
Western Acquisition Ventures (NASDAQ: WAVSU) Enters into Promissory Notes for Transaction Expenses with Cycurion Inc.
Western Acquisition Ventures Corp. filed a Form 8-K with the Securities and Exchange Commission on January 6, 2025, indicating the...
Walker River Resources (CVE:WRR) Trading Up 11.4% – Should You Buy?
Walker River Resources Corp. (CVE:WRR – Get Free Report) was up 11.4% during trading on Thursday . The company traded...